Searchable abstracts of presentations at key conferences in endocrinology

ea0081p411 | Pituitary and Neuroendocrinology | ECE2022

Independent injection vs healthcare-setting administration of somatostatin analogues: A systematic literature review

Luiz Boguszewski Cesar , Korbonits Marta , Artignan Audrey , Martin Garcia Almudena , Houchard Aude , Ribeiro-Oliveira Antonio , W de Herder Wouter

Background: A systematic literature review (SLR) was conducted to assess the use of independent injections (self/partner/home-administered) as an alternative to healthcare-setting injections for chronic diseases. The primary objective was to identify studies reporting on independent injection of somatostatin analogues (SSAs). Comparative evidence on independent injection of other medications was examined as a secondary objective.Methods: MEDLINE/Embase/t...

ea0081ep94 | Adrenal and Cardiovascular Endocrinology | ECE2022

The burden of illness associated with adolescent and adult congenital adrenal hyperplasia: results of a structured literature review

Sabar Uzmah , Coope Helen , Maskin Kamran , Parviainen Lotta , Porter John , Withe Mike , Woods Matthew

Objectives: Congenital adrenal hyperplasia (CAH) is a rare condition caused by enzyme deficiency in cortisol biosynthesis. The aim of this study was to evaluate the burden of illness associated with child/adolescent and adult CAH.Methods: A structured, comprehensive literature review was conducted to identify articles describing the burden and treatment landscape of CAH. Literature databases (MEDLINE, Embase, the Cochrane Library and EconLit), websites a...

ea0081ep636 | General Endocrinology | ECE2022

Di-Butyl-Phthalate (DBP) exposure impact on human masculine reproductive hormones. A review of literature

Nita Tiberiu , Paoloni-Giacobino Ariane , Stenz Ludwig , Vernez David , Hopf Nancy

Background: Phthalates are currently used in medical devices, adhesives as plasticizers. Masculine reproductive toxicity is the greatest concern associated with exposure, known as the “phthalate syndrome”. The European Chemicals Agency has recognized di-butyl-phthalate (DBP, CAS 84-74-2) as an endocrine disruptor with deleterious effects on reproductive hormones, with an estimated human intake of 0.84-5.22 μg/kg/day. Effects reported include the disruption of Se...

ea0089c32 | Clinical – Surgery/Applied Pathology | NANETS2022

Surgical Management of G3 Gastroenteropancreatic Neuroendocrine Neoplasms: A Systematic Review and Meta-Analysis

Ziogas, MD, MPH Ioannis A. , T. Tasoudis, MD Panagiotis , C. Borbon, MD Luis , K. Sherman, MD, FACS Scott , J. Breheny, MS, PhD Patrick , Chandrasekharan, MBBS Chandrikha , S. Dillon, MD Joseph , M. Bellizzi, MD Andrew , R. Howe, MD, FACS James

Background: Grade 3 (G3) gastroenteropancreatic (GEP) neuroendocrine neoplasms (NENs) are rare, aggressive tumors with poor prognosis. The WHO 2017 classification further subdivided G3 NENs into G3 neuroendocrine tumors (NETs) and neuroendocrine carcinomas (NECs). Current guidelines favor medical management in most of these patients, and the role of surgical management is not well-defined. We performed a systematic literature review and meta-analysis of surgical management vs ...

ea0089o1 | Other | NANETS2022

Efficacy and Toxicity of Anti-Vascular Endothelial Growth Factor (VEGF) Receptor Tyrosine Kinase Inhibitors (TKIs) in Neuroendocrine Tumors (NETs) – A Systematic Review and Meta-Analysis

Das, MD, MSCI Satya , Phillips, MSPH Sharon , M Lebeck Lee, MD Cody , Agarwal, MD, MSCI Rajiv , Bergsland, MD Emily , Strosberg, MD Jonathan , A. Chan, MD, MPH Jennifer , LaFerriere, MLIS Heather , A. Ramirez, DO Robert , Berlin, MD Jordan , Arvind Dasari, MD, MS and

Background: Although anti-VEGF RTKIs have been tested in patients with NETs over the last 2 decades, no study to date has benchmarked efficacy and toxicity of these drugs in this patient population.Methods: A literature search was performed to identify all phase II and phase III studies of anti-VEGF RTKIs in patients with NETs published between January 1, 2000 – July 31, 2021. Major trial databases (e.g. Medline, EMBASE, Cumulative Index of Nursing ...

ea0090p339 | Diabetes, Obesity, Metabolism and Nutrition | ECE2023

Therapy of overweight and obesity resistant to behavioral treatment in the adult population with metabolic comorbidities. A network meta-analysis

Samperi Irene , Persichetti Agnese , Attanasio Roberto , Busetto Luca , Cinquini Michela , Paoletta Agostino , Papini Enrico , Novizio Roberto , Scoppola Alessandro , Vettor Roberto , Chianelli Marco

Background: Overweight and obesity are an increasing concern for public health worldwide. Obesity is a chronic, progressive and relapsing disease associated with the development of several comorbidities which may improve after weight loss. The first step in the management of weight excess includes life-style modifications but, in the long-term, obesity is frequently resistant to life-style changes only. Surgical procedures and medical treatments have, therefore, been developed...

ea0090p404 | Pituitary and Neuroendocrinology | ECE2023

Prevalence of transient and permanent diabetes insipidus after transsphenoidal pituitary surgery: A systematic review and meta-analysis

Fountas Athanasios , Coulden Amy , Allotey John , Karavitaki Niki

Introduction: Patients undergoing transsphenoidal pituitary surgery (TPS) may develop water balance disorders post-operatively, with diabetes insipidus (DI) being the most common. Nonetheless, data on the prevalence of post-operative DI are not consistent necessitating a systematic review of the literature.Aim: To estimate the prevalence of DI following TPS in patients with pituitary adenomas (PAs), craniopharyngiomas and Rathke’s cleft cysts (RCCs)...

ea0090p454 | Reproductive and Developmental Endocrinology | ECE2023

Effect of selective oestrogen receptor modulators/aromatase inhibitors on semen parameters in men with secondary hypogonadism; systematic review and meta-analysis

Lakshitha de Silva Nipun , Dissanayake Harsha , Suarez Camila , Wickramarachchi R. E. , Ramasamy Ranjith , Dhillo Waljit , Minhas Suks , Corona Giovanni , Jayasena Channa

Introduction: Selective oestrogen receptor modulators (SERMs) and aromatase inhibitors (AIs) potentially increase endogenous gonadotrophin and testosterone secretion in men. They are used off-label in men with hypogonadism and/or infertility. There is a lack of guidance on using these agents in men with secondary hypogonadism, though these agents are widely used in these people as a cheaper alternative to gonadotrophins. Methods: Systematic search was co...

ea0090ep707 | Pituitary and Neuroendocrinology | ECE2023

Safety and efficacy of once weekly somapacitan versus once daily growth hormone among adults with growth hormone deficiency: A systematic review and meta-analysis

Co Faith Abigail , Baliclic Micah Fiel , Sese Kevin , Pagcatipunan Jr. Rodolfo S

Background: Adult growth hormone deficiency (AGHD) has been increasingly observed among patients with traumatic brain injury, stroke, and central nervous system infection, aside from the subgroup of patients with pituitary tumors. When left untreated, these patients have a significantly increased risk to develop cardiovascular morbidity and mortality and impaired psychosocial function. Existing treatment guidelines on AGHD have recommended the use of growth hormone (GH) replac...

ea0090ep986 | Thyroid | ECE2023

Thyroid hormone replacement during Ramadan fasting is a real challenge to hypothyroid patients. A systematic review and meta-analysis

Mohammed Rabea Eslam , Mohamed Belal Mohamed , Reda Youssef Asmaa , Awaad Elalaky Nessreen , Baker Hany , Adel Muhammed Quaisy Muhammed

Background: Ramadan is the religious month in which Muslims fast from pre-dawn (suhoor) until sunset (iftar), abstaining from all kinds of food, and liquid. The major change in meal times may be challenging for hypothyroid patients on levothyroxine because levothyroxine has a narrow therapeutic index and should be taken on an empty stomach.Objective: We aim to compare pre- and post-Ramadan Thyroid function tests of hypothyroid patients taking levothyroxi...